Schiller
Alfred Schiller, Aeugst A.a. CH
Patent application number | Description | Published |
---|---|---|
20110106190 | Defibrillator Having a Secure Discharging Circuit Comprising an H-Bridge - The invention relates to a cardiac defibrillator used to treat a patient in cardio-circulatory arrest by a shock from a dosed biphasic discharge from a capacitor through an H-bridge comprising a high-voltage switch A, B, C or D in each of the limbs thereof. Said cardiac defibrillator is characterised in that each opposing polarity phase of the biphasic shock is controlled in two stages in such a way that, for each pair of switches associated with a phase, the first switch is switched on and remains on during the entire phase, while the second switch switches off in a staggered manner in relation to the first switch for a controlled amount of time in order to pass the current through the patient during said phase, the same process being carried out for the second phase with the other pair of switches. The invention is especially suitable for manufacturers of defibrillation appliances. | 05-05-2011 |
Barak Schiller, Oxford GB
Patent application number | Description | Published |
---|---|---|
20130316310 | METHODS FOR DETERMINING ORIENTATION OF A MOVING VEHICLE - A method is provided for determining orientation of a moving vehicle. Using a fixed position device, the method comprises: collecting data which relate to acceleration forces measured along the vehicle axes together with corresponding GPS related information; calculating correlations between measured accelerations and velocity changes and/or vehicle's heading changes; associating the calculated correlations with a plurality of possible yaw rotation angles and derive therefrom a yaw rotation angle that maximizes the correlation; and based on a yaw rotation angle that would maximize the correlation derived, determining the orientation of the moving vehicle. Using a mobile device placed in the vehicle in an unknown position, the method comprises collecting data obtained by the mobile device during a driving session from a GPS and from acceleration measurements made by an accelerometer of the mobile device. | 11-28-2013 |
Dominic Schiller, Merseyside GB
Patent application number | Description | Published |
---|---|---|
20150359756 | USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY - The present disclosure relates to the use of cannabidiol (CBD) in the treatment of absence seizures. In particular, the disclosure relates to the use of CBD for reducing absence seizures in patients suffering with etiologies that include: Lennox-Gastaut Syndrome; Tuberous Sclerosis Complex; Dravet Syndrome; Doose Syndrome; CDKL5; Dup15q; Jeavons syndrome; Myoclonic Absence Epilepsy; Neuronal ceroid lipofuscinoses (NCL) and brain abnormalities. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs). | 12-17-2015 |
Frank R. Schiller, St.walburg CA
Patent application number | Description | Published |
---|---|---|
20150197176 | Pontoon Boat Loading Guide - An apparatus adapted to provide a loading guide for loading a pontoon boat onto a boat trailer includes a mounting plate to allow the guide to be mounted to the frame of a boat trailer and a wheel adapted to contact and guide a pontoon during loading. The wheel includes a center axis and a tire. The wheel center axis is mounted vertically so that the pontoon body will come in contact with the outer surface of the tire and the wheel will rotationally guide the pontoon down its length as the boat is loaded. A plurality of these guides are mounted on the boat trailer to provide a system of loading guides for optimum support of the pontoon boat during loading and unloading. | 07-16-2015 |
Irene Schiller, Kilchberg CH
Patent application number | Description | Published |
---|---|---|
20100150966 | METHOD FOR THE DIAGNOSIS OF TUBERCULOSIS - Method for the diagnosis of a tuberculosis infection caused by Mycobacteria belonging to the Mycobacteria tuberculosis complex group (MTC) in an animal including a human being, which comprises in vitro-detection of cell-mediated immune response to OmpAtb and/or antibodies against OmpAtb in a sample taken from that animal. | 06-17-2010 |
20130102491 | METHOD FOR THE DIAGNOSIS OF TUBERCULOSIS - A method for the diagnosis of a tuberculosis infection caused by Mycobacteria belonging to the Mycobacteria tuberculosis complex group (MTC) in an animal including a human being, which comprises in vitro-detection of cell-mediated immune response to OmpAtb and/or antibodies against OmpAtb in a sample taken from that animal. | 04-25-2013 |
Michael Schiller, Arnoldstein AT
Patent application number | Description | Published |
---|---|---|
20110143068 | STABILIZER COMPOSITION FOR HALOGEN-CONTAINING POLYMERS - The present invention relates to a stabilizer composition for halogen-containing polymers comprising titanium dioxide and at least one nitrogen-containing compound, wherein the titanium dioxide has a photo-electromotive force (photo-EMK) in the μs-range >−15 mV and a photo-electromotive force in the ms-range >+5 mV. | 06-16-2011 |
20110306695 | Tin-Free Stabilizer Composition - A stabilizer composition for halogenated polymers comprising at least one zinc salt of a carboxylic acid and/or of a β-diketone, comprising | 12-15-2011 |
20110311744 | HEAVY METAL-FREE STABILIZER COMPOSITION FOR HALOGENATED POLYMERS - The present invention relates to a stabilizer composition for halogen-containing polymers which is free from heavy metals, the use thereof in the stabilizing of halogen-containing polymers, in particular against an undesirable pink coloration, and shaped articles comprising this stabilizer composition. | 12-22-2011 |
Peter W. Schiller, Montreal CA
Patent application number | Description | Published |
---|---|---|
20100190718 | METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION - The invention provides a method of reducing or preventing mitochondrial permeability transitioning. The method comprises administering an effective amount of an aromatic-cationic peptide having at least one net positive charge; a minimum of four amino acids; a maximum of about twenty amino acids; a relationship between the minimum number of net positive charges (p | 07-29-2010 |
20120021970 | METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION - The invention provides a method of reducing or preventing mitochondrial permeability transitioning. The method comprises administering an effective amount of an aromatic-cationic peptide having at least one net positive charge; a minimum of four amino acids; a maximum of about twenty amino acids; a relationship between the minimum number of net positive charges (p | 01-26-2012 |
20120329730 | AROMATIC-CATIONIC PEPTIDES AND USES OF SAME - The disclosure provides aromatic-cationic peptide compositions and methods of preventing or treating disease using the same. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide to subjects in need thereof. | 12-27-2012 |
20130244957 | METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION - The invention provides a method of reducing or preventing mitochondrial permeability transitioning. The method comprises administering an effective amount of an aromatic-cationic peptide having at least one net positive charge; a minimum of four amino acids; a maximum of about twenty amino acids; a relationship between the minimum number of net positive charges (p | 09-19-2013 |
20130316964 | AROMATIC-CATIONIC PEPTIDES AND USES OF SAME - The disclosure provides aromatic-cationic peptide compositions and methods of preventing or treating disease using the same. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide to subjects in need thereof. | 11-28-2013 |
20150359838 | METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION - The invention provides a method of reducing or preventing mitochondrial permeability transitioning. The method comprises administering an effective amount of an aromatic-cationic peptide having at least one net positive charge; a minimum of four amino acids; a maximum of about twenty amino acids; a relationship between the minimum number of net positive charges (p | 12-17-2015 |
Richard Schiller, Chichester West Sussex GB
Patent application number | Description | Published |
---|---|---|
20140046718 | METHOD AND SYSTEM FOR QUEUE CONTROL - System comprising a queue control unit ( | 02-13-2014 |
Steven Robert Schiller, Westlock CA
Patent application number | Description | Published |
---|---|---|
20130233981 | COMBINED PROTECTOR AND HOSE SUPPORT DEVICE FOR CONTAINMENT BERM - The invention is directed to a combined protector and hose support device for a containment berm including an elongate bracket configured to be removably attached to the rim of the containment berm, and a saddle pivotally mounted to the bracket to engage the hose. | 09-12-2013 |